Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02358993 · ClinicalTrials.gov registry record · NA
Short-course Methenamine Hippurate for Prevention of Post-operative UTI
A NA study of Urinary Tract Infections and Catheter-Related Infections, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 201
- Enrollment target
- 4
- Study locations
NCT02358993: Completed NA study of Urinary Tract Infections and Catheter-Related Infections, sponsored by University of Pennsylvania.
NCT02358993 is a NA study of Urinary Tract Infections and Catheter-Related Infections that has completed, run by University of Pennsylvania. The registered enrollment target is 201 participants, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (56% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02358993, a NA study of Urinary Tract Infections and Catheter-Related Infections, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 201 participants
- Enrollment target
- 4
- Study locations
Study Summary
The investigators will determine the efficacy of an innovative short regimen of methenamine hippurate on prevention of post-operative UTI in patients requiring short-term catheterization after pelvic reconstructive surgery through a single-blind, randomized controlled trial. Primary outcome will be the rate of symptomatic UTI within 3 weeks of catheter removal. The investigators will study cost-effectiveness, antibiotic resistance profiles, and adverse drug effects. Findings may reduce antibiotic use and nosocomial UTIs.
Primary Outcome
This is defined as any symptomatic UTI requiring treatment with antibiotics as determined by the development of 2 or more of the following symptoms, in the absence of vaginal symptoms: urinary frequency; urinary urgency; dysuria; fever over 38oC/100.4oF; suprapubic, flank, or back pain; and/or chills.
Conditions Studied
Interventions
- DRUG Ciprofloxacin
- DRUG methenamine hippurate
Study Locations (4)
Pennsylvania
- Hospital of the University of Pennsylvania - Philadelphia
- Penn Presbyterian Medical Center - Philadelphia
- Pennsylvania Hospital - Philadelphia
- Chestnut Hill Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2014-12 |
| Est. Completion | 2020-09-30 |
| Phase | NA |
What the finished NCT02358993 record still lists
NCT02358993 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 452-participant average among 34 other Urinary Tract Infections trials with a reported enrollment target (56% lower).
The record links to 2 conditions, with Urinary Tract Infections appearing as the primary indexed condition, and to 2 interventions - of which Ciprofloxacin is the first listed.
NCT02358993 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02358993 about?
NCT02358993 is a clinical study titled "Short-course Methenamine Hippurate for Prevention of Post-operative UTI". The investigators will determine the efficacy of an innovative short regimen of methenamine hippurate on prevention of post-operative UTI in patients requiring short-term catheterization after pelvic reconstructive surgery through a single-blind, randomized controlled trial. Primary outcome will be ...
What is the current status of trial NCT02358993?
This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 2014-12. Estimated completion is 2020-09-30.
What conditions does trial NCT02358993 study?
This clinical trial studies the following conditions: Urinary Tract Infections, Catheter-Related Infections.
What interventions are being tested in trial NCT02358993?
The interventions under investigation include: Ciprofloxacin (DRUG), methenamine hippurate (DRUG).
Who is sponsoring clinical trial NCT02358993?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02358993 being conducted?
This trial has 4 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Tract Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02358993's enrollment target sits among peer trials
201 16th of 34 higher than 19 of 34 other Urinary Tract Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Tract Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Application of a Prediction Model for Directing Antibiotic Use in the Treatment of Urinary Tract Infection in an Ambulatory Setting
RECRUITING · NA
-
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
RECRUITING · NA
-
Double Voiding and Post-transplant UTI
RECRUITING · NA
-
Diagnosis and Treatment of Urinary Tract Infection Using DNA Polymerase Chain Reaction Versus Urine Culture
RECRUITING · NA
-
Effect of Standardization of Urine Collection Using PEEZY Device as Compared to Clean Peezy for DAB
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia